Company_Context
Healthcare
Drug Manufacturers
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
793 directional transactions in 90D
Code P purchases and code S sales are measured from 2026.05.19 — 2026.08.16.
-$389.4M
Open-market buys minus sales2026.08.13
Latest available filing15
Reporting entities in windowROTHBLATT MARTINE A
$863.9KROTHBLATT MARTINE A
$308.5MAnalysis of eligible SEC Form 4 activity for UTHR indicates a bearish 90-day signal. The selected window contains transactions from 15 distinct reporting insiders, with aggregate nominal activity of $489.96M.
Open-market purchases minus open-market sales produce a negative net flow of $389.36M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
ROTHBLATT MARTINE A recorded the largest aggregate purchase volume, while ROTHBLATT MARTINE A recorded the largest aggregate sale volume. Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Healthcare
Drug Manufacturers
0
Clustered open-market purchase records in the recent filing sample.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 90D headline signal window.
Open-market selling volume ($390.22M) currently exceeds buying volume ($0.86M), indicating net liquidation by insiders.
During the last 90 calendar days, ROTHBLATT MARTINE A (Executive) recorded the largest aggregate open-market purchase volume. Total insider buying in the window is $0.86M.
During the last 90 calendar days, eligible open-market sales total $390.22M. ROTHBLATT MARTINE A recorded the largest aggregate selling volume.
Performance pending
No matured open-market transaction with calculated market windows is available in the recent sample.
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.